Impact of proteasome inhibitor vs. IMiD maintenance therapy on outcomes of patients with high-risk multiple myeloma (HRMM).

被引：0
|
作者：
Tam, Eric Leon
Iberri, David Joseph
Liedtke, Michaela
Muffly, Lori S.
Shiraz, Parveen
Frank, Matthew Joshua
Lowsky, Robert
Rezvani, Andrew
Negrin, Robert
Meyer, Everett
Arai, Sally
Johnston, Laura J.
Shizuru, Judith
Weng, Wen-Kai
Miklos, David Bernard
Sidana, Surbhi
机构：
[1] Stanford Univ, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Stanford, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20557
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Impact of bortezomib-based versus lenalidomide maintenance therapy on outcomes of patients with high-risk multiple myeloma
    Bumma, Naresh
    Dhakal, Binod
    Fraser, Raphael
    Estrada-Merly, Noel
    Anderson, Kenneth
    Freytes, Cesar O.
    Hildebrandt, Gerhard C.
    Holmberg, Leona
    Krem, Maxwell M.
    Lee, Cindy
    Lekakis, Lazaros
    Lazarus, Hillard M.
    Mian, Hira
    Murthy, Hemant S.
    Nathan, Sunita
    Nishihori, Taiga
    Parrondo, Ricardo
    Patel, Sagar S.
    Solh, Melhem
    Strouse, Christopher
    Vesole, David H.
    Kumar, Shaji
    Qazilbash, Muzaffar H.
    Shah, Nina
    D'Souza, Anita
    Sidana, Surbhi
    CANCER, 2023, 129 (14) : 2179 - 2191
  • [2] Upfront 28-Day Metronomic Therapy for High-Risk Multiple Myeloma (HRMM)
    Thanendrarajan, Sharmilan
    Alapat, Daisy V.
    Zangari, Maurizio
    Schinke, Carolina
    Heuck, Christoph
    van Rhee, Frits
    Rosenthal, Adam
    Epstein, Joshua
    Yaccoby, Shmuel
    Davies, Faith E.
    Morgan, Gareth J.
    Barlogie, Bart
    BLOOD, 2015, 126 (23)
  • [3] High-Risk Cytogenetics Multiple Myeloma: Impact of Consolidation and Maintenance
    Jimenez-Zepeda, Victor
    Duggan, Peter
    Neri, Paola
    Tay, Jason
    Rashid-Kolvear, Fariborz
    Bahlis, Nizar J.
    BLOOD, 2016, 128 (22)
  • [4] Impact of clonal plasma cells in autografts on outcomes in high-risk multiple myeloma patients
    Pasvolsky, Oren
    Milton, Denai R.
    Rauf, Mikael
    Ghanem, Sassine
    Masood, Adeel
    Mohamedi, Ali H.
    Tanner, Mark R.
    Bashir, Qaiser
    Srour, Samer
    Saini, Neeraj
    Lin, Paul
    Ramdial, Jeremy
    Nieto, Yago
    Tang, Guilin
    Lee, Hans C.
    Patel, Krina K.
    Kebriaei, Partow
    Thomas, Sheeba K.
    Weber, Donna M.
    Orlowski, Robert Z.
    Rezvani, Katy
    Champlin, Richard
    Shpall, Elizabeth J.
    Lin, Pei
    Qazilbash, Muzaffar H.
    BLOOD CANCER JOURNAL, 2023, 13 (01)
  • [5] Impact of clonal plasma cells in autografts on outcomes in high-risk multiple myeloma patients
    Oren Pasvolsky
    Denái R. Milton
    Mikael Rauf
    Sassine Ghanem
    Adeel Masood
    Ali H. Mohamedi
    Mark R. Tanner
    Qaiser Bashir
    Samer Srour
    Neeraj Saini
    Paul Lin
    Jeremy Ramdial
    Yago Nieto
    Guilin Tang
    Hans C. Lee
    Krina K. Patel
    Partow Kebriaei
    Sheeba K. Thomas
    Donna M. Weber
    Robert Z. Orlowski
    Katy Rezvani
    Richard Champlin
    Elizabeth J. Shpall
    Pei Lin
    Muzaffar H. Qazilbash
    Blood Cancer Journal, 13
  • [6] Impact of Maintenance Therapy in High-Risk Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplantation
    Bashir, Qaiser
    Milton, Denai
    Popat, Uday R.
    Oran, Betul
    Nieto, Yago
    Kebriaei, Partow
    Ciurea, Stefan O.
    Ahmed, Sairah
    Mehta, Rohtesh S.
    Olson, Amanda
    Parmar, Simrit
    Alatrash, Gheath
    Hosing, Chitra M.
    Shah, Nina
    Patel, Krina
    Weber, Donna
    Thomas, Sheeba
    Manasanch, Elisabet
    Lee, Hans C.
    Orlowski, Robert Z.
    Champlin, Richard E.
    Qazilbash, Muzaffar H.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S243 - S244
  • [7] Maintenance therapy with bortezomib and dexamethasone after autotransplantation for high-risk multiple myeloma
    Mancuso, Katia
    Tacchetti, Paola
    Pantani, Lucia
    Rocchi, Serena
    Rizzello, Ilaria
    Caratozzolo, Isola
    De Cicco, Gabriella
    Fusco, Alessio
    Testoni, Nicoletta
    Terragna, Carolina
    Marzocchi, Giulia
    Martello, Marina
    Borsi, Enrica
    Dozza, Luca
    Cavo, Michele
    Zamagni, Elena
    BONE MARROW TRANSPLANTATION, 2020, 55 (09) : 1865 - 1867
  • [8] Maintenance therapy with bortezomib and dexamethasone after autotransplantation for high-risk multiple myeloma
    Katia Mancuso
    Paola Tacchetti
    Lucia Pantani
    Serena Rocchi
    Ilaria Rizzello
    Isola Caratozzolo
    Gabriella De Cicco
    Alessio Fusco
    Nicoletta Testoni
    Carolina Terragna
    Giulia Marzocchi
    Marina Martello
    Enrica Borsi
    Luca Dozza
    Michele Cavo
    Elena Zamagni
    Bone Marrow Transplantation, 2020, 55 : 1865 - 1867
  • [9] Serum indicators in functional high-risk multiple myeloma patients undertaking proteasome inhibitors therapy: a retrospective study
    Zhan, Linquan
    Yuan, Dai
    Ge, Xueling
    Ding, Mei
    Wang, Jianhong
    Zhou, Xiangxiang
    Wang, Xin
    HEMATOLOGY, 2024, 29 (01)
  • [10] Definition and therapy of high-risk Multiple Myeloma
    Willenbacher, W.
    Willenbacher, E.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 242 - 242
12345